Morningside

Morningside is a venture capital firm based in the greater Boston area, specializing in investments in companies that focus on innovative science and technology. Established in 1986 as a family office for the Chan family, Morningside emphasizes a long-term approach to company-building and maintains a strong commitment to ethical practices. The firm is staffed by a team of experienced investment professionals with expertise in various sectors, including life sciences, digital health, artificial intelligence, materials, and technology. In addition to its investment activities, Morningside is dedicated to philanthropic efforts, supporting education, research, and healthcare initiatives such as the Harvard T.H. Chan School of Public Health, UMass Chan Medical School, and the MIT Morningside Academy for Design.

Qin Liu

Co-Founder, Investment Director and Board Member

Michael Xue

Managing Director

Past deals in Child Care

SimpliFed

Seed Round in 2025
SimpliFed is a telehealth company founded in 2020 that offers virtual breastfeeding support to new and pregnant parents. The company focuses on providing accessible care during the peri and postnatal periods, addressing the challenges faced by parents, including sleep deprivation and concerns about infant nutrition. SimpliFed specializes in lactation and baby feeding support, as well as monitoring high-risk conditions such as hypertension and gestational diabetes. Through secure online and video-based connections, patients can engage with care navigators who guide them through their maternal care journey, helping them obtain quick answers to their questions about their infants' dietary needs.

Huckleberry Labs

Series A in 2021
Huckleberry makes behavioral expertise accessible and affordable to all families by combining AI with human experts, starting with children's sleep.

Cognoa

Series A in 2019
Cognoa, Inc. is a pediatric behavioral health company based in Palo Alto, California, that focuses on developing digital diagnostics and therapeutics aimed at improving the early diagnosis and treatment of behavioral health conditions, such as autism. The company offers an online application that allows parents and caregivers to assess their children's cognitive development by answering questions about behavior and submitting videos of their child at play. This tool provides scores and personalized recommendations, helping users understand their child's risk for autism and other developmental delays. Additionally, Cognoa's responsible artificial intelligence technology identifies subtle signs of developmental issues, enabling healthcare providers to gain insights that support informed diagnoses. The company's mission is to enhance the lives and outcomes of children and families affected by behavioral conditions.

Cognoa

Series A in 2016
Cognoa, Inc. is a pediatric behavioral health company based in Palo Alto, California, that focuses on developing digital diagnostics and therapeutics aimed at improving the early diagnosis and treatment of behavioral health conditions, such as autism. The company offers an online application that allows parents and caregivers to assess their children's cognitive development by answering questions about behavior and submitting videos of their child at play. This tool provides scores and personalized recommendations, helping users understand their child's risk for autism and other developmental delays. Additionally, Cognoa's responsible artificial intelligence technology identifies subtle signs of developmental issues, enabling healthcare providers to gain insights that support informed diagnoses. The company's mission is to enhance the lives and outcomes of children and families affected by behavioral conditions.

Cognoa

Series A in 2013
Cognoa, Inc. is a pediatric behavioral health company based in Palo Alto, California, that focuses on developing digital diagnostics and therapeutics aimed at improving the early diagnosis and treatment of behavioral health conditions, such as autism. The company offers an online application that allows parents and caregivers to assess their children's cognitive development by answering questions about behavior and submitting videos of their child at play. This tool provides scores and personalized recommendations, helping users understand their child's risk for autism and other developmental delays. Additionally, Cognoa's responsible artificial intelligence technology identifies subtle signs of developmental issues, enabling healthcare providers to gain insights that support informed diagnoses. The company's mission is to enhance the lives and outcomes of children and families affected by behavioral conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.